Stocks making the biggest moves after hours: Pinterest, Simon Property Group, Avis Budget and more

Stocks making the biggest moves after hours: Pinterest, Simon Property Group, Avis Budget and more


Check out the companies making headlines after the bell

Pinterest — Shares of the image-sharing company popped more than 19% despite a miss on the top and bottom lines as activist investor Elliott Management revealed it is now the largest investor. The company also beat monthly active user estimates.

Simon Property Group — Simon Property’s stock rose more than 1% in extended training despite a revenue miss. The REIT beat earnings estimates by 8 cents and shared earnings guidance for the full year that topped expectations.

Arista Networks — The cloud computing stock added 4.6% after hours following a beat on the top and bottom lines in the latest quarter. Arista Networks reported adjusted earnings of $1.08 per share on revenues of $1.05 billion and posted strong revenue guidance for the current quarter.

Avis Budget — The rental vehicle company gained 6% in extended trading on the back of a better-than-expected quarter. Avis Budget posted adjusted earnings per share of $15.94 per share on $3.24 billion in revenue. Analysts anticipated earnings of $11.48 a share on revenue of $3.17 billion.

ZoomInfo — Shares of ZoomInfo jumped 12% postmarket after topping earnings and revenue estimates for the most recent quarter. The company reported adjusted earnings of 21 cents per share on $267 million in revenue and lifted its guidance for the full year.



Source

This bargain fintech stock is stuck in a five-year rut. A turnaround is coming
Finance

This bargain fintech stock is stuck in a five-year rut. A turnaround is coming

Source

Read More
Stocks making the biggest moves premarket: AstraZeneca, Unity Software, Coinbase & more
Finance

Stocks making the biggest moves premarket: AstraZeneca, Unity Software, Coinbase & more

Check out the companies making the biggest moves premarket: AstraZeneca — The pharma giant rose 3% after its experimental drug, tozorakimab, was found to meaningfully reduce flare-ups in cases of chronic obstructive pulmonary disease. The drug delivered the results in two late-stage trials, and the company said full results will be delivered at an upcoming […]

Read More
Why one hedge fund veteran is urging investors to ‘prepare for the worst’
Finance

Why one hedge fund veteran is urging investors to ‘prepare for the worst’

ETF Edge Why one hedge fund veteran is urging investors to ‘prepare for the worst’ Published Fri, Mar 27 20267:00 AM EDT Blair Bao WATCH LIVE Source

Read More